Cargando…
Human iPSC-Derived Neural Models for Studying Alzheimer’s Disease: from Neural Stem Cells to Cerebral Organoids
During the past two decades, induced pluripotent stem cells (iPSCs) have been widely used to study mechanisms of human neural development, disease modeling, and drug discovery in vitro. Especially in the field of Alzheimer’s disease (AD), where this treatment is lacking, tremendous effort has been p...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930932/ https://www.ncbi.nlm.nih.gov/pubmed/35107767 http://dx.doi.org/10.1007/s12015-021-10254-3 |
_version_ | 1784671144238907392 |
---|---|
author | Barak, Martin Fedorova, Veronika Pospisilova, Veronika Raska, Jan Vochyanova, Simona Sedmik, Jiri Hribkova, Hana Klimova, Hana Vanova, Tereza Bohaciakova, Dasa |
author_facet | Barak, Martin Fedorova, Veronika Pospisilova, Veronika Raska, Jan Vochyanova, Simona Sedmik, Jiri Hribkova, Hana Klimova, Hana Vanova, Tereza Bohaciakova, Dasa |
author_sort | Barak, Martin |
collection | PubMed |
description | During the past two decades, induced pluripotent stem cells (iPSCs) have been widely used to study mechanisms of human neural development, disease modeling, and drug discovery in vitro. Especially in the field of Alzheimer’s disease (AD), where this treatment is lacking, tremendous effort has been put into the investigation of molecular mechanisms behind this disease using induced pluripotent stem cell-based models. Numerous of these studies have found either novel regulatory mechanisms that could be exploited to develop relevant drugs for AD treatment or have already tested small molecules on in vitro cultures, directly demonstrating their effect on amelioration of AD-associated pathology. This review thus summarizes currently used differentiation strategies of induced pluripotent stem cells towards neuronal and glial cell types and cerebral organoids and their utilization in modeling AD and potential drug discovery. GRAPHICAL ABSTRACT: [Image: see text] |
format | Online Article Text |
id | pubmed-8930932 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-89309322022-04-01 Human iPSC-Derived Neural Models for Studying Alzheimer’s Disease: from Neural Stem Cells to Cerebral Organoids Barak, Martin Fedorova, Veronika Pospisilova, Veronika Raska, Jan Vochyanova, Simona Sedmik, Jiri Hribkova, Hana Klimova, Hana Vanova, Tereza Bohaciakova, Dasa Stem Cell Rev Rep Article During the past two decades, induced pluripotent stem cells (iPSCs) have been widely used to study mechanisms of human neural development, disease modeling, and drug discovery in vitro. Especially in the field of Alzheimer’s disease (AD), where this treatment is lacking, tremendous effort has been put into the investigation of molecular mechanisms behind this disease using induced pluripotent stem cell-based models. Numerous of these studies have found either novel regulatory mechanisms that could be exploited to develop relevant drugs for AD treatment or have already tested small molecules on in vitro cultures, directly demonstrating their effect on amelioration of AD-associated pathology. This review thus summarizes currently used differentiation strategies of induced pluripotent stem cells towards neuronal and glial cell types and cerebral organoids and their utilization in modeling AD and potential drug discovery. GRAPHICAL ABSTRACT: [Image: see text] Springer US 2022-02-02 2022 /pmc/articles/PMC8930932/ /pubmed/35107767 http://dx.doi.org/10.1007/s12015-021-10254-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Barak, Martin Fedorova, Veronika Pospisilova, Veronika Raska, Jan Vochyanova, Simona Sedmik, Jiri Hribkova, Hana Klimova, Hana Vanova, Tereza Bohaciakova, Dasa Human iPSC-Derived Neural Models for Studying Alzheimer’s Disease: from Neural Stem Cells to Cerebral Organoids |
title | Human iPSC-Derived Neural Models for Studying Alzheimer’s Disease: from Neural Stem Cells to Cerebral Organoids |
title_full | Human iPSC-Derived Neural Models for Studying Alzheimer’s Disease: from Neural Stem Cells to Cerebral Organoids |
title_fullStr | Human iPSC-Derived Neural Models for Studying Alzheimer’s Disease: from Neural Stem Cells to Cerebral Organoids |
title_full_unstemmed | Human iPSC-Derived Neural Models for Studying Alzheimer’s Disease: from Neural Stem Cells to Cerebral Organoids |
title_short | Human iPSC-Derived Neural Models for Studying Alzheimer’s Disease: from Neural Stem Cells to Cerebral Organoids |
title_sort | human ipsc-derived neural models for studying alzheimer’s disease: from neural stem cells to cerebral organoids |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930932/ https://www.ncbi.nlm.nih.gov/pubmed/35107767 http://dx.doi.org/10.1007/s12015-021-10254-3 |
work_keys_str_mv | AT barakmartin humanipscderivedneuralmodelsforstudyingalzheimersdiseasefromneuralstemcellstocerebralorganoids AT fedorovaveronika humanipscderivedneuralmodelsforstudyingalzheimersdiseasefromneuralstemcellstocerebralorganoids AT pospisilovaveronika humanipscderivedneuralmodelsforstudyingalzheimersdiseasefromneuralstemcellstocerebralorganoids AT raskajan humanipscderivedneuralmodelsforstudyingalzheimersdiseasefromneuralstemcellstocerebralorganoids AT vochyanovasimona humanipscderivedneuralmodelsforstudyingalzheimersdiseasefromneuralstemcellstocerebralorganoids AT sedmikjiri humanipscderivedneuralmodelsforstudyingalzheimersdiseasefromneuralstemcellstocerebralorganoids AT hribkovahana humanipscderivedneuralmodelsforstudyingalzheimersdiseasefromneuralstemcellstocerebralorganoids AT klimovahana humanipscderivedneuralmodelsforstudyingalzheimersdiseasefromneuralstemcellstocerebralorganoids AT vanovatereza humanipscderivedneuralmodelsforstudyingalzheimersdiseasefromneuralstemcellstocerebralorganoids AT bohaciakovadasa humanipscderivedneuralmodelsforstudyingalzheimersdiseasefromneuralstemcellstocerebralorganoids |